Ticker Report Andra AP fonden grew its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 125.9% in the second quarter, Holdings Channel reports. The institutional investor owned 83,800...\n more…
Ticker Report Edwards Lifesciences (NYSE:EW - Get Free Report) had its price target lowered by investment analysts at UBS Group from $90.00 to $75.00 in a research report issued to clients and investors on...\n more…
Benzinga Investors with a lot of money to spend have taken a bullish stance on Edwards Lifesciences EW. And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.\n more…